Standard BioTools News

Standard BioTools (LAB.US) was first covered by TD Cowen, which gave it a buy rating, with a target price of $3.50.

Zhitong FinanceApr 16 06:20

Standard BioTools Analyst Ratings

BenzingaApr 16 06:13

TD Cowen Initiates Coverage On Standard BioTools With Buy Rating, Announces Price Target of $3.5

BenzingaApr 16 06:15

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Standard BioTools (LAB)

TipRanksApr 4 07:10

Standard BioTools Analyst Ratings

BenzingaApr 4 06:20

Jefferies Initiates Coverage On Standard BioTools With Buy Rating, Announces Price Target of $3.25

BenzingaApr 4 06:21

KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology

MT NewswiresJul 12, 2023 07:18

Analysts Have Conflicting Sentiments on These Healthcare Companies: Centene (CNC) and Standard BioTools (LAB)

TipRanksJul 12, 2023 03:30

Keybanc Initiates Coverage On Standard BioTools With Overweight Rating, Announces Price Target of $4

BenzingaJul 12, 2023 03:29

Standard BioTools Analyst Ratings

BenzingaJul 12, 2023 03:28